BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26876206)

  • 1. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling.
    Bernaudo S; Salem M; Qi X; Zhou W; Zhang C; Yang W; Rosman D; Deng Z; Ye G; Yang BB; Vanderhyden B; Wu Z; Peng C
    Oncogene; 2016 Sep; 35(36):4816-27. PubMed ID: 26876206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
    Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
    Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
    Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/β-catenin pathway.
    Miao W; Lu T; Liu X; Yin W; Zhang H
    Cancer Biomark; 2020; 28(4):459-471. PubMed ID: 32538821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
    Salem M; Shan Y; Bernaudo S; Peng C
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3
    Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P
    Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.
    Cheng Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
    Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
    Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible role in preeclampsia.
    Sun M; Gao J; Meng T; Liu S; Chen H; Liu Q; Xing X; Zhao C; Luo Y
    FASEB J; 2021 Feb; 35(2):e21169. PubMed ID: 33205477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.